Updates on Dose Conversion Ratio Between Two Botulinum Toxin A Preparations When Injected in the Sweat Glands

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.10, Iss.5, 2009-10, pp. : 347-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Botulinum Toxin for Hyperhidrosis: A Review

By Grunfeld Alexander

American Journal of Clinical Dermatology, Vol. 10, Iss. 2, 2009-01 ,pp. : 87-102

Adis International

Access to resources Recommend Favorite

Botulinum Toxin A: Its Expanding Role in Dermatology and Esthetics

By Said S.Z.

American Journal of Clinical Dermatology, Vol. 4, Iss. 9, 2003-01 ,pp. : 609-616

Adis International

Access to resources Recommend Favorite

Managing Adverse Events Associated with Botulinum Toxin Type A: A Focus on Cosmetic Procedures

By Wollina Uwe Konrad Helga

American Journal of Clinical Dermatology, Vol. 6, Iss. 3, 2005-01 ,pp. : 141-150

Adis International

Access to resources Recommend Favorite

Botulinum Toxin: Examining Duration of Effect in Facial Aesthetic Applications

By >

American Journal of Clinical Dermatology, Vol. 11, Iss. 3, 2010-06 ,pp. : 183-199

Adis International

Access to resources Recommend Favorite

Botulinum Toxin for Glabellar Lines: A Review of the Efficacy and Safety of Currently Available Products

By Dessy Luca A.

American Journal of Clinical Dermatology, Vol. 12, Iss. 6, 2011-12 ,pp. : 377-388

Adis International

Access to resources Recommend Favorite